Brevan Howard Capital Management’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RPRX
Brevan Howard Capital Management's RPRX Position: Q2 2026 in Review
Brevan Howard Capital Management increased its Royalty Pharma (RPRX) stake by 3.6% in Q2 2026, buying an estimated $149K and bringing the position to 82,435 shares worth $4.62M. The position accounts for 0.03% of the portfolio, ranked #362.
Brevan Howard Capital Management first reported a position in RPRX in Q4 2023 and has held it in 3 quarters since. 643 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.
- Brevan Howard Capital Management held 82,435 shares of Royalty Pharma worth $4.62M as of Q2 2026.
- Brevan Howard Capital Management bought 2,857 Royalty Pharma shares in Q2 2026, an estimated $149K.
- Royalty Pharma made up 0.03% of Brevan Howard Capital Management's portfolio in Q2 2026, its #362 holding.
- Brevan Howard Capital Management first reported a position in Royalty Pharma in Q4 2023 and has held it in 3 quarters since.
- 643 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.
Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.